We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




DePuy Acquires Assets of Orquest

By HospiMedica staff writers
Posted on 20 Feb 2003
In a move to expand its orthobiologic offerings, DePuy AcroMed, Inc. More...
(Raynham, MA, USA) has acquired substantially all of the assets of Orquest, Inc. (Mountain View, CA, USA), a company focused on developing biologic-based implants for orthopedics and spine surgery. Terms were not disclosed.

Orquest's patented technologies and materials for regenerating cartilage, accelerating fracture repair, and augmenting bone formation are key assets that fit directly into the existing orthobiologic initiatives at DePuy, says the company. Orquest's principal product, Healos bone graft material, is designed to reduce the time and pain associated with standard bone graft harvesting. It is used in conjunction with the patient's own bone marrow. Orquest's product development efforts have focused on further enhancing bone formation by combining Healos with the bone morphogenic protein (BMP) molecule (MP52) now licensed to DePuy. These product-development efforts will be integrated into DePuy's scientific, clinical, and regulatory programs. Healos/MP52 is now in human clinical trials in Europe.

"In conjunction with our recent exclusive, worldwide license with Biopharm, GmbH, for a broad BMP technology portfolio, DePuy is positioned for solid leadership in the future of musculoskeletal tissue repair and regeneration,” said Nicholas Valeriani, a Johnson & Johnson Company group chairman with responsibility for DePuy.





Related Links:
DePuy
Orquest

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Hypodermic Syringe
SurTract™ Safety Syringe
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Allevion Medical receives FDA Clearance for Vantage, introducing a fully disposable approach to minimally invasive spinal decompression (photo courtesy of Allevion Medical)

Single-Use System Enables Minimally Invasive Decompression for Lumbar Spinal Stenosis

Lumbar spinal stenosis is frequently driven by hypertrophic bone that narrows the canal and produces pain. Conventional decompression often relies on larger incisions and bulky retractors, adding time,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.